Germany's BVMed sets up diabetes sector working group
This article was originally published in Clinica
German medtech industry association BVMed has established a diabetes sector working group, representing manufacturers and distributors in the insulin pump therapy and continuous glucose monitoring segments.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.